[Crystepin CH. A multi-centre trial of an antihypertensive drug (author's transl)].
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002752:Chlorthalidone / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003005:Clopamide; D025442:Dihydroergocristine; D004088:Dihydroergotoxine / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D054833:Isoindoles; D008297:Male; D008875:Middle Aged; D012110:Reserpine / Q000009:adverse effects / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D004338:Drug Combinations; D054833:Isoindoles; C032077:clopamide, dihydroergochristine, reserpine drug combination; D025442:Dihydroergocristine; D004088:Dihydroergotoxine; D003005:Clopamide; D012110:Reserpine; D002752:Chlorthalidone
Crystepin CH. Multicentrické hodnocení antihypertenzíva.